A$0.75 ($0.52)

+0.01 (+2.04%)

Weekly Expected Move ±3.7%

A$1 A$1 A$1 A$1 A$1

ASX · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 42 · A$286.4M mcap · 295M float · 0.221% daily turnover

Revenue

$269M -0.9% ▼

5Y CAGR: +8.0%

Gross Profit

$62M -31.4% ▼

5Y CAGR: +1.4%

Operating Income

$21M -52.4% ▼

5Y CAGR: -10.1%

Net Income

$7M -70.3% ▼

5Y CAGR: -21.7%

EPS (Diluted)

$0.02 -70.3% ▼

5Y CAGR: -21.6%

EBITDA

$44M -17.0% ▼

5Y CAGR: -3.0%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$192M	$214M	$255M	$272M	$269M
YoY Growth	+4.7%	+11.1%	+19.4%	+6.7%	-0.9%
Cost of Revenue	$135M	$150M	$169M	$182M	$208M
Gross Profit	$57M	$63M	$86M	$90M	$62M
Gross Margin	29.8%	29.7%	33.5%	33.2%	23.0%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$73M	$81M	$97M	$24M	$41M
Operating Expenses	$26M	$28M	$91M	$47M	$41M
Operating Income	$31M	$33M	-$6M	$43M	$21M
Operating Margin	16.1%	15.5%	-2.2%	16.0%	7.7%
Interest Expense	$2M	$3M	$5M	$7M	$9M
Income Before Tax	$26M	$30M	-$11M	$36M	$11M
Tax Expense	$8M	$8M	-$5M	$10M	$3M
Net Income	$18M	$22M	-$7M	$25M	$7M
Net Margin	9.6%	10.2%	-2.6%	9.2%	2.8%
EPS (Diluted)	$0.05	$0.06	$-0.02	$0.06	$0.02
EBITDA	$43M	$48M	$11M	$53M	$44M
Shares Outstanding	392M	392M	390M	391M	391M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$103M	$110M	$126M	$130M	$140M	$132M	$138M	$132M
Cost of Revenue	$73M	$77M	$88M	$87M	$93M	$89M	$105M	$103M
Gross Profit	$30M	$33M	$38M	$42M	$48M	$43M	$33M	$29M
Gross Margin	29.4%	30.0%	30.1%	32.5%	34.0%	32.3%	24.2%	21.7%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$14M	$15M	$87M	$10M	$11M	$13M	$18M	$14M
Operating Expenses	$14M	$15M	$18M	$68M	$20M	$27M	$18M	$23M
Operating Income	$17M	$18M	$20M	-$26M	$28M	$16M	$15M	$5M
Operating Margin	16.3%	16.5%	16.1%	-20.0%	19.8%	11.9%	10.8%	4.0%
Interest Expense	$2M	$2M	$3M	$3M	$3M	$4M	$4M	$5M
Income Before Tax	$15M	$15M	$18M	-$28M	$24M	$12M	$10M	$904K
Tax Expense	$4M	$4M	$5M	-$10M	$7M	$3M	$3M	$123K
Net Income	$11M	$11M	$13M	-$19M	$17M	$8M	$7M	$265K
Net Margin	10.3%	10.2%	10.2%	-14.9%	12.1%	6.1%	5.2%	0.2%
EPS (Diluted)	$0.03	$0.03	$0.03	$-0.05	$0.04	$0.02	$0.02	$0.00
EBITDA	$24M	$24M	$30M	-$19M	$39M	$27M	$27M	$16M
Shares Outstanding	393M	392M	393M	390M	393M	390M	392M	390M

MVF.AX ASX